Jan Haviernik

733 total citations
18 papers, 360 citations indexed

About

Jan Haviernik is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases and Parasitology. According to data from OpenAlex, Jan Haviernik has authored 18 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Public Health, Environmental and Occupational Health, 12 papers in Infectious Diseases and 7 papers in Parasitology. Recurrent topics in Jan Haviernik's work include Mosquito-borne diseases and control (13 papers), Viral Infections and Vectors (10 papers) and Vector-borne infectious diseases (6 papers). Jan Haviernik is often cited by papers focused on Mosquito-borne diseases and control (13 papers), Viral Infections and Vectors (10 papers) and Vector-borne infectious diseases (6 papers). Jan Haviernik collaborates with scholars based in Czechia, Slovakia and Belgium. Jan Haviernik's co-authors include Daniel Růžek, Luděk Eyer, Michal Štefánik, Martina Fojtíková, Ivo Rudolf, Zdeněk Hubálek, Erik De Clercq, Noël Tordo, Radim Nencka and Jana Širmarová and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and Journal of Virology.

In The Last Decade

Jan Haviernik

17 papers receiving 353 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan Haviernik Czechia 11 193 149 68 66 51 18 360
Rawiwan Im‐Erbsin Thailand 13 148 0.8× 238 1.6× 68 1.0× 46 0.7× 68 1.3× 36 434
Deepali Savargaonkar India 13 112 0.6× 250 1.7× 38 0.6× 91 1.4× 35 0.7× 31 450
Diego Allonso Brazil 14 256 1.3× 348 2.3× 24 0.4× 101 1.5× 77 1.5× 30 559
Roslaini Abd Majid Malaysia 11 56 0.3× 167 1.1× 133 2.0× 109 1.7× 64 1.3× 39 456
Jennifer L. Güler United States 12 47 0.2× 220 1.5× 57 0.8× 151 2.3× 95 1.9× 26 393
Wenn-Chyau Lee Malaysia 14 47 0.2× 354 2.4× 128 1.9× 77 1.2× 41 0.8× 25 459
Francis E. G. Cox United Kingdom 5 52 0.3× 243 1.6× 77 1.1× 59 0.9× 34 0.7× 7 393
Supriya Sharma India 11 75 0.4× 177 1.2× 25 0.4× 79 1.2× 19 0.4× 45 438
Stefanie K. Menzies United Kingdom 12 73 0.4× 47 0.3× 46 0.7× 127 1.9× 72 1.4× 22 381
Mary Lynn Baniecki United States 8 96 0.5× 223 1.5× 59 0.9× 65 1.0× 57 1.1× 17 377

Countries citing papers authored by Jan Haviernik

Since Specialization
Citations

This map shows the geographic impact of Jan Haviernik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Haviernik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Haviernik more than expected).

Fields of papers citing papers by Jan Haviernik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Haviernik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Haviernik. The network helps show where Jan Haviernik may publish in the future.

Co-authorship network of co-authors of Jan Haviernik

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Haviernik. A scholar is included among the top collaborators of Jan Haviernik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Haviernik. Jan Haviernik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Kunka, Antonín, Hana Hříbková, Tereza Váňová, et al.. (2025). Modulation of Amyloid-β Aggregation by Surface Proteins from Pathogens Associated with Alzheimer’s Disease. ACS Chemical Neuroscience. 16(18). 3554–3566.
2.
Leoni, Stefania, et al.. (2025). Three-dimensional mapping of tick-borne encephalitis virus distribution in the mouse brain using a newly engineered TurboGFP reporter virus. Emerging Microbes & Infections. 14(1). 2542246–2542246. 2 indexed citations
3.
Štefánik, Michal, Petra Straková, Jan Haviernik, et al.. (2024). Nanoformulation of the Broad-Spectrum Hydrophobic Antiviral Vacuolar ATPase Inhibitor Diphyllin in Human Recombinant H-ferritin. International Journal of Nanomedicine. Volume 19. 3907–3917. 1 indexed citations
4.
Svoboda, Pavel, Jan Haviernik, Milos Matkovic, et al.. (2023). A combination of two resistance mechanisms is critical for tick-borne encephalitis virus escape from a broadly neutralizing human antibody. Cell Reports. 42(9). 113149–113149. 5 indexed citations
5.
Slavíková, Monika, Jan Haviernik, Václav Hönig, et al.. (2022). Fitness of mCherry Reporter Tick-Borne Encephalitis Virus in Tick Experimental Models. Viruses. 14(12). 2673–2673. 1 indexed citations
6.
Štefánik, Michal, Jan Haviernik, Petra Straková, et al.. (2022). Diphyllin Shows a Broad-Spectrum Antiviral Activity against Multiple Medically Important Enveloped RNA and DNA Viruses. Viruses. 14(2). 354–354. 19 indexed citations
7.
Bednářová, Klára, Jan Haviernik, Jiří Černý, et al.. (2022). Guanine quadruplexes in the RNA genome of the tick-borne encephalitis virus: their role as a new antiviral target and in virus biology. Nucleic Acids Research. 50(8). 4574–4600. 13 indexed citations
8.
Štefánik, Michal, Petra Straková, Jan Haviernik, et al.. (2021). Antiviral Activity of Vacuolar ATPase Blocker Diphyllin against SARS-CoV-2. Microorganisms. 9(3). 471–471. 22 indexed citations
9.
Salát, Jiřı́, Petra Formanová, Aleš Chrdle, et al.. (2020). Tick-Borne Encephalitis Virus Vaccines Contain Non-Structural Protein 1 Antigen and May Elicit NS1-Specific Antibody Responses in Vaccinated Individuals. Vaccines. 8(1). 81–81. 30 indexed citations
11.
Štefánik, Michal, James J. Valdés, Jan Haviernik, et al.. (2020). FDA-Approved Drugs Efavirenz, Tipranavir, and Dasabuvir Inhibit Replication of Multiple Flaviviruses in Vero Cells. Microorganisms. 8(4). 599–599. 21 indexed citations
12.
Haviernik, Jan, Luděk Eyer, Antoine Nougaırède, et al.. (2020). An E460D Substitution in the NS5 Protein of Tick-Borne Encephalitis Virus Confers Resistance to the Inhibitor Galidesivir (BCX4430) and Also Attenuates the Virus in Mice. SHILAP Revista de lepidopterología. 12–12. 1 indexed citations
13.
Haviernik, Jan, Trevor P. Anderson, David R. Murdoch, et al.. (2020). Complete Genome Sequence of a Legionella longbeachae Serogroup 2 Isolate Derived from a Patient with Legionnaires’ Disease. Microbiology Resource Announcements. 9(5). 1 indexed citations
14.
Eyer, Luděk, Pavel Svoboda, Jan Balvan, et al.. (2020). Broad-Spectrum Antiviral Activity of 3′-Deoxy-3′-Fluoroadenosine against Emerging Flaviviruses. Antimicrobial Agents and Chemotherapy. 65(2). 11 indexed citations
15.
Eyer, Luděk, Antoine Nougaırède, Jean‐Sélim Driouich, et al.. (2019). An E460D Substitution in the NS5 Protein of Tick-Borne Encephalitis Virus Confers Resistance to the Inhibitor Galidesivir (BCX4430) and Also Attenuates the Virus for Mice. Journal of Virology. 93(16). 36 indexed citations
16.
Strouhal, Michal, Lenka Mikalová, Jan Haviernik, et al.. (2018). Complete genome sequences of two strains of Treponema pallidum subsp. pertenue from Indonesia: Modular structure of several treponemal genes. PLoS neglected tropical diseases. 12(10). e0006867–e0006867. 17 indexed citations
17.
Haviernik, Jan, Michal Štefánik, Martina Fojtíková, et al.. (2018). Arbidol (Umifenovir): A Broad-Spectrum Antiviral Drug That Inhibits Medically Important Arthropod-Borne Flaviviruses. Viruses. 10(4). 184–184. 100 indexed citations
18.
Eyer, Luděk, Jana Širmarová, Martina Fojtíková, et al.. (2017). Antiviral activity of the adenosine analogue BCX4430 against West Nile virus and tick-borne flaviviruses. Antiviral Research. 142. 63–67. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026